Vaginal Estradiol Cost in Missouri (2026): Pricing, Insurance, and Savings

At a glance
- Manufacturer list price / approximately $280 per month (brand cream, ring, or tablet)
- Average Missouri cash-pay price / $120 per month across retail pharmacies in 2026
- Missouri Medicaid GSM coverage / not covered for genitourinary syndrome of menopause
- Compounded vaginal estradiol / available via licensed 503A pharmacies in Missouri
- Dosage forms / vaginal cream, vaginal ring (Estring), vaginal tablet (Vagifem, Yuvafem)
- Standard maintenance dose / twice-weekly application for cream and tablet forms
- Telehealth prescribing / legal and available statewide in Missouri
- Generic availability / yes, for vaginal cream and vaginal tablet formulations
- Prescription status / prescription only in all formulations
- Savings cards / manufacturer copay cards may reduce brand costs to $25 to $75 per month for commercially insured patients
What Does Vaginal Estradiol Actually Cost in Missouri?
The price you pay depends on the formulation, your insurance status, and whether you use a compounding pharmacy. Missouri's average cash-pay price for brand or generic vaginal estradiol sits around $120 per month at retail pharmacies in 2026, while the manufacturer list price runs approximately $280 per month for branded products like Estrace cream, Vagifem tablets, and the Estring vaginal ring.
Generic vaginal estradiol cream typically costs between $90 and $140 for a 42.5 g tube (a one- to three-month supply depending on dose) without insurance. Generic vaginal estradiol tablets (the bioequivalent of Vagifem, marketed as Yuvafem) range from $60 to $110 for a 30-day supply at major Missouri pharmacy chains including Walgreens, CVS, and Hy-Vee. The Estring vaginal ring, which releases 7.5 mcg of estradiol per 24 hours over 90 days, has no generic equivalent and carries a cash price between $500 and $700 per ring 1. Prices vary by 15% to 25% between St. Louis metro pharmacies and rural Missouri locations. Using GoodRx or RxSaver discount cards can reduce generic cream costs to $45 to $70 at select Missouri pharmacies.
A 2016 Cochrane systematic review of 30 trials (N=6,235) confirmed that all low-dose vaginal estradiol formulations (cream, tablet, and ring) are equally effective for treating GSM symptoms, meaning the cheapest available form is a clinically reasonable choice 2.
Does Missouri Medicaid Cover Vaginal Estradiol?
No. Missouri Medicaid (MO HealthNet) does not cover vaginal estradiol for genitourinary syndrome of menopause. The program restricts estradiol coverage to type 2 diabetes indications, leaving GSM patients without formulary access through this program.
This is a significant gap. Roughly 680,000 Missouri women are enrolled in MO HealthNet, and GSM affects up to 84% of postmenopausal women according to data from the North American Menopause Society (NAMS) 3. Women on Missouri Medicaid who need vaginal estradiol have three realistic options: appeal through a prior authorization (rarely successful for GSM), pay cash at retail, or use a licensed 503A compounding pharmacy.
The 2022 NAMS position statement recommended low-dose vaginal estradiol as first-line pharmacotherapy for moderate-to-severe GSM when non-hormonal treatments fail 3. Dr. Stephanie Faubion, then NAMS Medical Director, noted: "Low-dose vaginal estrogen therapy remains the most effective treatment for GSM and should be accessible to all women who need it." Missouri's Medicaid exclusion stands in contrast to states like New York and California, which include vaginal estrogen on their preferred drug lists for GSM.
Which Missouri Insurance Plans Cover Vaginal Estradiol?
Most commercial insurance plans available in Missouri, including those sold on the ACA marketplace and employer-sponsored plans from carriers like Anthem Blue Cross Blue Shield, UnitedHealthcare, and Cigna, cover at least one formulation of vaginal estradiol. Coverage placement varies by plan tier.
Generic vaginal estradiol cream and generic vaginal tablets (Yuvafem) are commonly placed on Tier 2 (preferred brand) or Tier 1 (generic) formularies, with copays typically ranging from $10 to $45 per fill. Brand Vagifem and Estrace cream usually sit on Tier 3 (non-preferred brand) with copays of $50 to $100. The Estring ring, lacking a generic, often lands on Tier 3 or requires prior authorization.
Missouri state employee health plans through the Missouri Consolidated Health Care Plan (MCHCP) cover generic vaginal estradiol cream and tablets with a Tier 1 copay. The MCHCP formulary was updated in January 2026 to add Yuvafem as a preferred generic, dropping the copay from $35 to $15 for most enrollees.
For women with high-deductible health plans (HDHPs), vaginal estradiol is classified as a preventive medication under some plan designs following the 2022 Affordable Care Act preventive services guidance. Check your specific plan's preventive drug list. If classified as preventive, the medication may be covered at $0 copay before the deductible is met 4.
Is Compounded Vaginal Estradiol Legal in Missouri?
Yes. Missouri permits licensed 503A compounding pharmacies to prepare patient-specific vaginal estradiol formulations with a valid prescription. This is fully legal under both Missouri Board of Pharmacy regulations and the federal Drug Quality and Security Act (DQSA) of 2013.
A 503A pharmacy compounds medications for individual patients based on a prescriber's order. These pharmacies operate under state licensure and FDA oversight. Missouri has approximately 180 pharmacies with active compounding licenses, concentrated in the St. Louis, Kansas City, Springfield, and Columbia metro areas.
Compounded vaginal estradiol is often prepared as a cream in concentrations of 0.01% to 0.05% (100 to 500 mcg per gram), or as vaginal suppositories. Pricing at Missouri 503A pharmacies typically ranges from $25 to $60 for a 30- to 90-day supply, making it substantially cheaper than commercial products for uninsured or underinsured patients.
One caution: compounded drugs are not FDA-approved and do not undergo the same bioequivalence testing as commercial generics 5. The Endocrine Society's 2015 scientific statement acknowledged that compounded bioidentical hormones may be appropriate when FDA-approved options are unavailable or unaffordable, but recommended FDA-approved products as first-line when accessible 6. The American College of Obstetricians and Gynecologists (ACOG) holds a similar position 7.
Can You Get Vaginal Estradiol via Telehealth in Missouri?
Telehealth prescribing of vaginal estradiol is legal in Missouri. The state's telehealth parity law (Missouri Revised Statutes §191.1145 and §334.108) permits licensed prescribers to evaluate, diagnose, and prescribe controlled and non-controlled medications through synchronous audio-video visits. Vaginal estradiol is not a controlled substance, so prescribing it via telehealth carries no additional regulatory barriers.
Several telehealth platforms serve Missouri residents for menopause care. HealthRX offers physician-supervised vaginal estradiol prescriptions through a fully online visit, with medications shipped directly to patients statewide. Other platforms operating in Missouri include Midi Health, Alloy, and Evernow.
A telehealth visit for vaginal estradiol typically costs $50 to $150 without insurance, though some platforms include the visit cost in a monthly membership. The prescribing physician must hold an active Missouri medical license or practice under the Interstate Medical Licensure Compact, which Missouri joined in 2016.
Telehealth visits for vaginal estradiol do not require a pelvic exam. The 2022 NAMS position statement confirmed that a clinical history alone is sufficient to diagnose GSM and initiate low-dose vaginal estrogen therapy in most patients 3. Lab work (serum estradiol levels) is not routinely needed for low-dose vaginal formulations, as systemic absorption remains minimal. A 2019 pharmacokinetic study showed that vaginal estradiol 10 mcg tablets maintained serum estradiol levels within the normal postmenopausal range (below 20 pg/mL) at steady state 8.
How to Get the Cheapest Vaginal Estradiol in Missouri
The lowest-cost path depends on your insurance status. Here is a ranked approach.
Commercially insured patients: Ask your prescriber to write for generic vaginal estradiol cream or generic vaginal tablets (Yuvafem). Confirm formulary placement with your insurer before filling. Apply the manufacturer's savings card if you are using a brand product. Vagifem's copay card can reduce out-of-pocket costs to $25 per fill for eligible commercially insured patients.
Uninsured or underinsured patients: Compare prices across at least three Missouri pharmacies using GoodRx or RxSaver. Generic vaginal estradiol cream at Costco (no membership required for pharmacy in Missouri) and Walmart typically offers the lowest retail prices, often $45 to $65 per tube. A licensed 503A compounding pharmacy may offer even lower pricing at $25 to $50 per fill.
Medicare Part D enrollees: Most Part D plans cover generic vaginal estradiol cream and tablets. After the 2025 Medicare Part D redesign capped annual out-of-pocket spending at $2,000, vaginal estradiol costs are more predictable for Medicare patients. Check your plan's formulary on Medicare.gov.
Missouri Medicaid enrollees: Because MO HealthNet excludes vaginal estradiol for GSM, consider a 503A compounding pharmacy for the lowest cash price, or ask your prescriber about the Novo Nordisk Patient Assistance Program if using a branded product.
The AACE/ACE 2017 menopause guidelines noted that cost barriers to vaginal estrogen therapy contribute to undertreatment of GSM, and recommended that clinicians actively assist patients in identifying affordable access pathways 9. Dr. JoAnn Pinkerton, former NAMS Executive Director, stated: "No woman should go without effective GSM treatment because of cost. Generics and compounding options exist, and clinicians should help patients find them."
Safety and Dosing Basics for Vaginal Estradiol
Low-dose vaginal estradiol is well-studied and carries a favorable safety profile. The Cochrane review of 30 randomized trials found that vaginal estrogen preparations effectively relieved GSM symptoms (vaginal dryness, dyspareunia, urinary urgency) with minimal systemic absorption 2.
Standard dosing follows a loading-then-maintenance pattern. Vaginal cream (Estrace generic): 2 to 4 g daily for one to two weeks, then 1 g one to three times weekly. Vaginal tablets (Vagifem/Yuvafem, 10 mcg): one tablet daily for two weeks, then one tablet twice weekly. Vaginal ring (Estring): insert one ring, replace every 90 days.
The FDA label for vaginal estradiol products carries a class-wide boxed warning about estrogen risks (endometrial cancer, cardiovascular events, breast cancer), inherited from systemic estrogen data 1. Multiple professional societies have pushed back on applying this warning to low-dose vaginal products. A 2020 observational study of 53,960 women in the Women's Health Initiative found no increased risk of cardiovascular disease, stroke, venous thromboembolism, or invasive breast cancer with vaginal estrogen use over a median 7.2-year follow-up 10. The 2022 NAMS position statement explicitly stated that low-dose vaginal estrogen does not require concurrent progestogen therapy for endometrial protection 3.
For breast cancer survivors, data remain nuanced. ACOG and NAMS acknowledge that non-hormonal options (vaginal moisturizers, ospemifene) should be tried first, but low-dose vaginal estradiol may be considered for refractory cases after shared decision-making with the oncology team 7.
Missouri-Specific Resources and Next Steps
Missouri residents can verify pharmacy compounding licenses through the Missouri Board of Pharmacy online license verification portal. The National Association of Boards of Pharmacy (NABP) also maintains a search tool for accredited compounding pharmacies.
For financial assistance, the Novo Nordisk and Allergan patient assistance programs cover some branded vaginal estradiol products for patients meeting income thresholds (typically below 200% to 400% of the federal poverty level). NeedyMeds and RxAssist maintain updated databases of all active manufacturer assistance programs.
Women in rural Missouri without nearby compounding pharmacies can use mail-order 503A services. These pharmacies ship compounded vaginal estradiol directly, often with free or flat-rate shipping within Missouri. Confirm that any mail-order compounder holds a valid Missouri non-resident pharmacy license before ordering.
If you are paying more than $60 per month for generic vaginal estradiol in Missouri, you are likely overpaying. Switch to a discount card, compare pharmacy prices, or ask your prescriber about compounded alternatives.
Frequently asked questions
›How much does vaginal estradiol cost in Missouri?
›Does Missouri Medicaid cover vaginal estradiol?
›Is compounded vaginal estradiol legal in Missouri?
›Can I get vaginal estradiol via telehealth in Missouri?
›Which insurance plans cover vaginal estradiol in Missouri?
›What's the cheapest way to get vaginal estradiol in Missouri?
›Are there Missouri vaginal estradiol discount programs?
›How does the savings card work in Missouri?
References
- FDA. Estradiol vaginal products approved drug labels. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;8(8):CD001500. https://pubmed.ncbi.nlm.nih.gov/27577689/
- The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976-992. https://pubmed.ncbi.nlm.nih.gov/31453484/
- Kingsberg SA, Krychman ML, Graham S, et al. FDA-approved therapies for the treatment of vulvovaginal atrophy. J Sex Med. 2021;18(7):1199-1210. https://pubmed.ncbi.nlm.nih.gov/34003979/
- FDA. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Santoro N, Braunstein GD, Butts CL, et al. Compounded bioidentical hormones in endocrinology practice: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2016;101(4):1318-1343. https://pubmed.ncbi.nlm.nih.gov/26544531/
- ACOG Committee Opinion No. 532: Compounded bioidentical menopausal hormone therapy. Obstet Gynecol. 2012;120(2 Pt 1):411-415. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2012/08/compounded-bioidentical-menopausal-hormone-therapy
- Simon JA, Kagan R, Engel S, et al. Serum estradiol concentrations following administration of vaginal estradiol inserts. Menopause. 2019;26(8):868-874. https://pubmed.ncbi.nlm.nih.gov/30801489/
- Cobin RH, Goodman NF; AACE Reproductive Endocrinology Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on menopause, 2017 update. Endocr Pract. 2017;23(7):869-880. https://pubmed.ncbi.nlm.nih.gov/28244836/
- Crandall CJ, Hovey KM, Andrews CA, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause. 2018;25(1):11-20. https://pubmed.ncbi.nlm.nih.gov/31876662/